Interleukin-18 in Hemophagocytic Lymphohistiocytosis

References

• Risdall R J, McKenna R W, Nesbit M E, Krivit W, Balfour HH, Jr, Simmons R L, Brunning R D. Virus-associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993–1002
   PubMed Web of Science ®Google Scholar
• Cline M J. Histiocytes and histiocytosis. Blood 1994; 84: 2840–2853
   PubMed Web of Science ®Google Scholar
• Sullivan J L, Woda B A. Lymphohistiocytic disorders, In Hematology of Infancy and Childhood, D. G. Nathan, F. A. Oski. WB, Saunders, Philadelphia 1997; 5th: p1359
   Google Scholar
• Tsuda H. Hemophagocytic syndrome in children and adults. International Journal of Hematology 1997; 65: 215–226
   PubMed Web of Science ®Google Scholar
• Dufourcq-Lagelouse R, Pastural E, Barrat F J, Feldmann J, Le Deist F, Fischer A, De Saint Basile G. Genetic basis of hemophagocytic lymphohistiocytosis syndrome. International Journal of Molecular Medicine 1999; 4: 127–133
   PubMed Web of Science ®Google Scholar
• Stepp S E, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew P A, Henter J I, Bennett M, Fischer A, de Saint Basile G, Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957–1959
   PubMed Web of Science ®Google Scholar
• Stepp S E, Mathew PA, Bennett M, de Saint Basile G, Kumar V. Perforin: more than just an effector molecule. Immunology Today 2000; 21: 254–256
   PubMedGoogle Scholar
• Spaner D, Raju K, Rabinovich B, Miller R G. A role for perforin in activation-induced T cell death in vivo: Increased expansion of allogeneic perforin-deficient T cells in SCID mice. Journal of Immunology 1999; 162: 1192–1199
   PubMed Web of Science ®Google Scholar
• Rossi C P, McAllister A, Tanguy M, Kagi D, Brahic M. Theiler's virus infection of perforin-deficient mice. Journal of Virology 1998; 72: 4515–4519
   PubMed Web of Science ®Google Scholar
• Matloubian M, Surech M, Glass A, Galvan M, Chow K, Whitraire J K, Walsh C M, Clark W R, Ahmed R. A role for perforin in downregulating T-cell responses during chronic viral infeciton. Journal of Virology 1999; 7: 2527–2536
   Google Scholar
• Ghiasi H, Cai S, Perng G, Nesburn A B, Wechsler S L. Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring. Virus Research 1999; 65: 97–101
   PubMed Web of Science ®Google Scholar
• Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. International Journal of Hematology 1997; 66: 135–151
   PubMed Web of Science ®Google Scholar
• Duval M, Fenneteau O, Doireau V, Faye A, Emilie D, Yotnda P, Drapier J C, Schlegel N, Sterkers G, de Baulny H O, Vilmer E. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. Journal of Pediatrics 1999; 134: 236–239
   PubMed Web of Science ®Google Scholar
• Imashuku S, Ikushima S, Esumi N, Todo S, Saito M. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Leukemia and lymhoma 1991; 3: 287–292
   PubMed Web of Science ®Google Scholar
• Henter J-I, Elinder G, Soder O, Hansson M, Anderson B, Anderson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918–2922
   PubMed Web of Science ®Google Scholar
• Sonneveld P, Lom K, Kappers-Klumme M, Prins M E, Abels J. Clinicopathological diagnosis and treatment of malignant histiocytosis. British Journal of Haematology 1990; 75: 511–516
   PubMed Web of Science ®Google Scholar
• Komp D M, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989; 73: 2128–2132
   PubMed Web of Science ®Google Scholar
• Osugi Y, Hara J, Togawa S, Takai K, Hosoi G, Matuda Y, Ohta H, Fujisawa H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S, Tawa A. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 4100–4103
   PubMed Web of Science ®Google Scholar
• Ishii E, Ohga S, Aoki T, Tamada S, Sako M, Tasaka H, Kuwano A, Sasaki M, Tsunematsu Y, Ueda K. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematologica 1991; 85: 93–99
   PubMed Web of Science ®Google Scholar
• Akashi K, Hayashi S, Gondo H, Mizuno S, Harada M, Tamura K, Yamasaki K, Shibuya T, Uike N, Okamura T, Miyamoto T, Niho Y. Involvement of interferon-γ and macrophage colony-stimulation factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. British Journal of Haematology 1994; 87: 243–250
   PubMed Web of Science ®Google Scholar
• Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infection & Immunity 1989; 57: 590–595
   PubMed Web of Science ®Google Scholar
• Lay J-D, Tsao C-J, Chen J-Y, Kadin M E, Su I-J. Upregulation of tumor necrosis factor-α in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. Journal of Clinical Investigation 1997; 100: 1969–1979
   PubMed Web of Science ®Google Scholar
• Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, Kai T, Suda M, Ueda K. Inflammatory cytokines in virus-associated hemophagocytic syndrome. American Journal of Pediatric Hematology Oncology 1993; 15: 291–298
   PubMedGoogle Scholar
• Fujiwara E, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. American Journal of Pediatric Hematology Oncology 1993; 15: 92–98
   PubMedGoogle Scholar
• Hasegawa D, Kojima S, Tatsumi E, Hayakawa A, Kosaka Y, Nakamura H, Sako M, Osugi Y, Nagata S, Sano K. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 1998; 91: 2793–2799
   PubMed Web of Science ®Google Scholar
• Nakamura K, Okamura H, Nagata K, Komatsu T, Tamura T. Purification of a factor which provides a costimulatory signal for γ interferon production. Infection & Immunity 1993; 61: 64–70
   PubMed Web of Science ®Google Scholar
• Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M. Cloning of a new cytokine that induced EFN-γ production by T cells. Nature 1995; 378: 88–91
   PubMed Web of Science ®Google Scholar
• Stoll S, Müller G, Kurimoto M, Saloga J, Tanimono T, Yamauchi H, Okamura H, Knop J, Enk H. Production of IL-18 (IFN-γ -inducing factor) mRNA and functional protein by murine keratinocytes. Journal of Immunology 1997; 159: 298–302
   PubMed Web of Science ®Google Scholar
• Olee T, Hashimoto S, Quach J, Lotz. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. Journal of Immunology 1999; 15; 162: 1096–1100
   Web of Science ®Google Scholar
• Udagawa N, Horwood N J, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers T J, Martin T J, Gillespie M T. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. Journal of Experimental Medicine 1997; 185: 1005–1012
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Nishizaki Y, Sano O, Ohta T, Ikeda M, Kurimoto M. Immunohistochemical and immune-electron-microscopic detection of interferon-γ -inducing factor (“interleukin-18”) in mouse intestinal epithelial cells. Cell & Tissue Research 1997; 289: 499–503
   PubMed Web of Science ®Google Scholar
• Cameron L A, Taha R A, Tsicopoulos A, Kurimoto M, Olivenstein R, Wallaert B, Minshall E M, Hamid Q A. Airway epithelium expresses interleukin-18. European Respiratory Journal 1999; 14: 553–559
   PubMed Web of Science ®Google Scholar
• McUlhane A C, Hall M D, Rothwell N J, Luheshi G N. Cloning of rat brain interleukin-18 cDNA. Molecular Psychiatry 1998; 3: 362–366
   PubMed Web of Science ®Google Scholar
• Conti B, Sugama S, Kim Y, Tinti C, Kim H, Baker H, Volpe B, Attardi B, Joh T. Modulation of IL-18 production in the adrenal cortex following acute ACTH or chronic corticosterone treatment. Neuroimmunomodulation 2000; 8: 1–7
   PubMed Web of Science ®Google Scholar
• Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming M A, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell R A, Sato V, Harding M W, Livingston D J, Su M S. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997; 275: 206–209
   PubMed Web of Science ®Google Scholar
• Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H, Kurimoto M. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. Journal of Immunology 1996; 156: 4274–4279
   PubMed Web of Science ®Google Scholar
• Micallef M J, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Fukuda S, Kurimoto M. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Europian Journal of Immunology 1996; 26: 1647–1651
   PubMed Web of Science ®Google Scholar
• Matsui K, Yoshimoto T, Tsutsui H, Hyodo Y, Hayashi N, Hiroshi K, Kawada N, Okamura H, Nakashima K, Higashino K. Propionibacterium acnes treatment diminishes CD4+NK1.1+ T cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. Journal of Immunology 1997; 159: 97–106
   PubMed Web of Science ®Google Scholar
• Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M. IFN-γ -inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. Journal of Immunology 1997; 158: 1541–1550
   PubMed Web of Science ®Google Scholar
• Puren A J, Fantuzzi G, Gu Y, Su MS-S, Dinarello CA. Interleukin-18 (IFN-γ -inducing factor) induced IL-8 and IL-1β via TNF-α production from non-CD14+human blood mononuclear cells. Journal of Clinical Investigation 1998; 101: 711–721
   PubMed Web of Science ®Google Scholar
• Tsutui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, Kaneda K. IFN-γ -inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. Journal of Immunology 1996; 157: 3967–3973
   PubMed Web of Science ®Google Scholar
• Galle P R, Hofmann W T, Walczak H, Schaller H, Otto G, Stremmel W, Krammer P H, Runkel L. Involvement of the CD95 (Apo-1/Fas) receptor and ligand in liver damage. Journal of Experimental Medicine 1995; 182: 1223–1230
   PubMed Web of Science ®Google Scholar
• Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatae K, Alan H D, Nagata S. Fas ligand in human serum. Nature Medicine 1996; 2: 317–322
   PubMed Web of Science ®Google Scholar
• Kondo T, Suda T, Fukayama H, Adachi M, Nagata S. Essential roles of Fas ligand in the development of hepatitis. Nature Medicine 1997; 3: 409–413
   PubMed Web of Science ®Google Scholar
• Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. Interferon-γ -inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper cells. Cellular Immunology 1996; 173: 230–235
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Tsuji-Takayama K, Aizawa Y, Koide K, Takeuchi M, Ohta T, Kurimoto M. Interleukin-18 activates NF-kB in murine T helper typel cells. Biochemical & Biophysical Research Communications 1997; 234: 454–457
   PubMed Web of Science ®Google Scholar
• Kohka H, Yoshino T, Iwagaki H, Sakuma I, Tanimoto T, Matsuo Y, Kurimoto M, Orita K, Akagi T, Tanaka N. Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. Journal of Leukocyte Biology 1998; 64: 519–527
   PubMed Web of Science ®Google Scholar
• Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, Akira S. Role of interleukin-18 (IL-18) in mycobacteria] infection in IL-18-gene-disrupted mice. Infection & Immunity 1999; 67: 2585–2589
   PubMed Web of Science ®Google Scholar
• Mastroeni P, Clare S, Khan S, Harrison J A, Hormaeche C E, Okamura H, Kurimoto M, Dougan G. Interleukin-18 contributes to host resistance and gamma interferon production in mice infected with virulent. Salmonella typhimurium. Infection & Immunity 1999; 67: 478–483
   PubMed Web of Science ®Google Scholar
• Dybing J K, Walters N, Pascual D W. Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections. Infection & Immunity 1999; 67: 6242–6248
   PubMed Web of Science ®Google Scholar
• Kawakami K, Koguchi Y, Qureshi M H, Kinjo Y, Yara S, Miyazato A, Kurimoto M, Takeda K, Akira S, Saito A. Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice. FEMS Immunology & Medical Microbiology 2000; 186: 121–126
   Web of Science ®Google Scholar
• Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. Journal of Virology 1999; 73: 2401–2409
   PubMed Web of Science ®Google Scholar
• Xing Z, Zganiacz A, Wang J, Divangahi M, Nawaz F. IL-12-independent Th1-type immune responses to respiratory viral infection: requirement of IL-18 for IFN-gamma release in the lung but not for the differentiation of viral-reactive Th1-type lymphocytes. Journal of Immunology 2000; 164: 2575–2584
   PubMed Web of Science ®Google Scholar
• Leung B P, McInnes I B, Esfandiari E, Wei X Q, Liew F Y. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. Journal of Immunology 2000; 164: 6495–6502
   PubMed Web of Science ®Google Scholar
• Wild J S, Sigounas A, Sur N, Siddiqui M S, Alam R, Kurimoto M, Sur S. JPN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. Journal of Immunology 2000; 164: 2701–2710
   PubMed Web of Science ®Google Scholar
• Daemen M A, van't Veer C, Wolfs T G, Buurman W A. Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. Journal of Immunology 1999; 162: 5506–5510
   PubMed Web of Science ®Google Scholar
• Hochholzer P, Lipford G B, Wagner H, Pfeffer K, Heeg K. Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infection & Immunigy 2000; 68: 3502–3508
   PubMed Web of Science ®Google Scholar
• Garcia V E, Uyemura K, Sieling P A, Ochoa M T, Morita C T, Okamura H, Kurimoto M, Rea T H, Modlin R L. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. Journal of Immunology 1999; 162: 6114–6121
   PubMed Web of Science ®Google Scholar
• Yamada G, Shijubo N, Shigehara K, Okamura H, Kurimoto M, Abe S. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. American Journal of Respiratory & Critical Care Medicine 2000; 161: 1786–1789
   PubMed Web of Science ®Google Scholar
• Fassbender K, Mielke O, Bertsch T, Muehlhauser F, Hennerici M, Kurimoto M, Rosso S. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology 1999; 53: 1104–1106
   PubMed Web of Science ®Google Scholar
• Grade J A, Forsey R J, Chan W L, Gilmour A, Leung B P, Greer M R, Kennedy K, Carter R, Wei X Q, Xu D, Field M, Foulis A, Liew F Y, McInnes I B. A proinflammatory role for IL-18 in rheumatoid arthritis. Journal of Clinical Investigation 1999; 104: 1393–401
   PubMed Web of Science ®Google Scholar
• Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, Luzza F, Fusco A, Pallone F. Bioactive IL-18 expression is up-regulated in Crohn's disease. Journal of Immunology 1999; 163: 143–147
   PubMed Web of Science ®Google Scholar
• Lauw F N, Simpson A J, Prins J M, Smith M D, Kurimoto M, van Deventer S J, Speelman P, Chaowagul W, White N J, van der Poll T. Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. Journal of Infectious Diseases 1999; 180: 1878–1885
   PubMed Web of Science ®Google Scholar
• McGuinness P H, Painter D, Davies S, McCaughan G W. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 2000; 46: 260–269
   PubMed Web of Science ®Google Scholar
• Urushihara N, Iwagaki H, Yagi T, Kohka H, Kobashi K, Morimoto Y, Yoshino T, Tanimoto T, Kurimoto M, Tanaka N. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. Pediatric Surgery 2000; 35: 446–449
   PubMed Web of Science ®Google Scholar
• Ida A, Tsuji Y, Muranaka J, Kanazawa R, Nakata Y, Adachi S, Okamura H, Koyama K. IL-18 in pregnancy; the elevation of IL-18 in maternal peripheral blood during labour and complicated pregnancies. Journal of Reproductive Immunology 2000; 47: 65–74
   PubMed Web of Science ®Google Scholar
• Takada H, Ohga S, Mizuno Y, Suminoe A, Matsuzaki A, Ihara K, Kinukawa N, Ohshima K, Kohno K, Kurimoto M, Hara T. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. British Journal of Haematology 1999; 106: 182–189
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, Nakanishi K. IL-18 accounts for both TNF-alpha-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. Journal of Immunology 1997; 159: 3961–3967
   PubMed Web of Science ®Google Scholar
• Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of T cell lineage. Journal of Immunology 1995; 154: 3806–3813
   PubMed Web of Science ®Google Scholar
• Medvedev A E, Johnsen A C, Haux J, Steinkjer B, Egeberg K, Lymch D H, Sundan A, Espevik T. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 1997; 9: 394–404
   PubMed Web of Science ®Google Scholar
• Arico M, Janka G, Fischer A, Henter J I, Blanche S, Elinder G, Martinetti M, Rusca M R. Hemophagocytic lymphohistiocytosis. Report of children from the International Registry. FEL Study Group of the Histiocyte Society. Leukemia 1996; 10: 197–203
   PubMed Web of Science ®Google Scholar
• Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. Journal of Pediatrics 1997; 130: 352–357
   PubMed Web of Science ®Google Scholar
• Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K, Akira S. Defective NK cell activity and Thl response in IL-18-deficient mice. Immunity 1998; 8: 383–390
   PubMed Web of Science ®Google Scholar
• Kist A, Ho A D, Räth U, Wiedenmann B, Bauer A, Schlick E, Kirchner H, Männel DN. Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor. Blood 1988; 72: 344–348
   PubMed Web of Science ®Google Scholar